required to elucidate their potential role in the progression of diabetic glomerulosclerosis. Background. Recent studies suggest that dyslipidaemia accelerates the progression of diabetic nephropathy,
lipoproteins (LDL) from eight diabetic patients with Introduction moderate impairment of renal function and dyslipidaemia and studied their interaction with LDL receptors
The incidence and prevalence of renal failure secondary in human glomerular epithelial cells.
to non-insulin-dependent diabetes mellitus (NIDDM ) Results. While diabetic VLDL showed no composiincreased over recent years [1] and vascular comorbidtional changes, LDL particles contained a higher proity in combination with dyslipidaemia is prominent in portion of triglycerides at the expense of cholesterol in such patients. Recent data also suggest that dyslipidaecomparison with healthy controls. Despite diÂerences mia may play a role in the progression of diabetic in composition, both VLDL and LDL from patients nephropathy [2] [3] [4] [5] . Although lipoprotein abnormalitexhibited reduced receptor aÃnity and cellular uptake ies in patients with diabetes mellitus are recognized as capacity by glomerular epithelial cells. Since LDL an accompaning metabolic disorder [6 ] , altered lipocomposition was altered intracellular cholesterol protein metabolism has not extensively been studied homeostasis was investigated. Due to reduced cholesin the pathogenesis of diabetic glomerulosclerosis in terol content and lower uptake capacity, diabetic LDL man. Animal experiments have established a role of were less eÂective in suppressing intracellular sterol abnormal lipid metabolism on the formation of glomersynthesis and in activating acylcholesterol acyltransferular lesions [7, 8] and similar pathogenetic mechanisms ase than LDL from controls. Electrophoretic mobility for the development of glomerulosclerosis and atheroof apoB from diabetic patients was enhanced as comsclerosis have been proposed [9 ] . Both the mesangium pared to controls, most probably due to the higher and glomerular epithelial cells may be involved in the degree of glycation ( 17+1.7 versus 11+1%, P<0.05) development of glomerular lesions in diabetic nephrobut not to oxidation ( TBARS 0.5+0.2 versus pathy. Glomerular epithelial cells express LDL recep-0.2+0.1 mmol/l ). Oxidized LDL was not taken up in tors and preferentially take up apoB and apoE significant amounts, indicating no scavenger receptor containing lipoproteins via receptor mediated endoactivity in glomerular epithelial cells. cell lines showed the same morphological and immunological characteristics as described by Kreisberg and Karnowski [17] . Immunochemical characterization was performed using the peroxidase-antiperoxidase ( PA) method according to
Methods
Bross et al. [18] .
Patients Lipid and apolipoprotein analysis
Blood was drawn from eight NIDDM patients (4 female, 4 male, mean age 64.9±9 years; range 48-76 years) and serum Cholesterol, triglycerides and phospholipids were determined was isolated for the studies performed in vitro. Patients were enzymatically on an automated analyser ( Wako R-30, Wako, diagnosed as having diabetic nephropathy according to the Neuss, Germany). Lipoprotein concentrations were deterduration of type II diabetes mellitus (mean 11±5 years) and mined using a combined ultracentrifugation and precipitation the presence of retinopathy, microalbuminuria, or pro-procedure as described in the 'Manual of Laboratory teinuria. There was no evidence for the presence of microhae-Operations' of the Lipid Research Clinics [19 ] with slight maturia or previous nephropathies in these NIDDM patients. modifications [20 ] . Apolipoprotein B (apoB) was determined All patients had pronounced hypertriglyceridaemia (serum by kinetic nephelometry (Array Protein System, Beckman, triglycerides>300 mg/dl ). Their mean body weight and BMI Brea, CA). ApoE was measured by endpoint nephelometry were elevated (83 kg and 30.2 kg/m2 respectively). using a nephelometer from Behring ( Marburg, Germany). Laboratory characteristics of the patients and healthy con-ApoE phenotyping was performed by immunofixation in trols are given in Table 1 . Eight normoglycaemic, normolipa-agarose as described previously [21 ] . The protein content of emic subjects without evidence for any underlying renal cells and lipoproteins was measured according to the Lowry disease acted as controls. Four patients were treated with an method. The degree of glycation of apoB was determined angiotensin-converting enzyme inhibitor at the time they with the 'Glycacor' enzyme immunoassay from Exocell were sampled. No patient was on immunosuppressive or (Philadelphia, PV, USA). The concentration of glycated lipid-lowering drugs. Informed consent was obtained from apoB was expressed as percentage of the total serum apoB. all patients.
Isolation, subfractionation, oxidation, and Cell cultures radioiodination of LDL Glomerular epithelial cells. Glomerular epithelial cells were VLDL (d<1.006 kg/l ) and LDL (d=1.019-1.060 kg/l ) were isolated from patients undergoing tumour nephrectomy. isolated from fasting citrated (3.8 g/l ) plasma by sequential Glomeruli were prepared using a sieving technique as ultracentrifugation [22 ] , dialysed against 5 mol/l Tris-HCl, described previously [11] . Briefly, isolated glomeruli were pH 7.4, 154 mmol/l NaCl, 250 mmol/l EDTA·Na 2 , and sterilincubated with collagenase I for 30 min at 37°C. After ized by passage through a 0.45-mm filter (Millipore, washing twice in DMEM/F 12 medium and following sedi-Molsheim, France). Purity of lipoproteins was tested by mentation cycles, aside from glomeruli almost no other agarose gel electrophoresis ( REP-HDL-plus cholesterol elecparticles could be detected. Glomeruli were suspended in trophoresis, Helena Diagnostika, Hartheim, Germany). DMEM/F 12 medium supplemented with 10% heat-Subfractionation of LDL. Total LDL (d=1.019-1.060 kg/l ) inactivated FCS, glutamine 2.5 mmol/l, sodium pyruvate were separated into six classes by equilibrium density gradient 0.1 mmol/l, HEPES buÂer 5 mmol/l, penicillin 105 U/l, centrifugation as described [23 ] . Density ranges of the streptomycin 100 mg/l, non-essential amino acids ( 100×) subfractions as determined by precision refractometry [24 ] 0.1× and insulin-transferrin-sodium selenite supplement of blank gradients were: LDL-1<1.031 kg/l; LDL-2 1.031-1.034 kg/l; LDL-3 1.034-1.037 kg/l; LDL-4 1.037-1.040 kg/l; LDL-5 1.040-1.044 kg/l; LDL-6 1.044- per ml ) was oxidized by incubation with CuSO 4 ( 5 mmol/l ) for 24 h at 23°C as described [25 ] . The degree of oxidation was assessed by the increase in mobility on agarose gel formed by the method of McFarlane [27] as modified by Bilheimer et al. [28] . 125I-LDL and VLDL were sterilized and used within 2 weeks.
Data are given as mean±SEM.
A. Krämer-Guth et al. 1338 The composition of LDL in NIDDM patients as compared to healthy controls was altered significantly. Cellular sterol synthesis and cholesterol esterification LDL of diabetic individuals exhibited a twofold higher content of triglycerides per particle, whereas free choCell cultures were incubated in DMEM medium containing lesterol, cholesterol ester and phospholipids were 10 % (v/v) LDS for 48 h and thereafter with varying concenreduced ( Table 3) . In contrast to LDL, VLDL particles trations of lipoproteins for 12 h. Cellular sterol synthesis was estimated from the rate of incorporation of (14C ) acetate showed no significant compositional changes between ( Du Pont, Dreieich, Germany) into sterols. Cellular choles-NIDDM patients and healthy controls. The ratio of terol esterification was measured as described [29, 30] . All apoE/B in LDL was not diÂerent between patients experiments were performed in duplicate.
and controls. Subfractionation of LDL revealed that the increase in LDL in the diabetic patients was due to both Statistics elevations of the concentrations of LDL-1 Results are reported as means±standard error of the mean (1.019-1.031 kg/l ) and LDL-6 ( 1.044-1.063 kg/l ) (SEM ). Comparison of means was performed using paired (Figure 1 ). or unpaired Student's t test as appropriate. one individual in each group was apoE3/4 hetero- Apart from alterations in the lipid composition of LDL, apoB is thought to be structurally modified in diabetic LDL and VLDL. The concentration of glycated apoB, determined by enzyme immunoassay, showed a significant elevation in NIDDM patients ( Table 2 ) .
In order to detect lipid peroxides in LDL, thiobarbituric acid reactive substances (TBARS ) were determined. Diabetic LDL only showed a slight increase in oxidation products compared to control LDL ( 0.5±0.2 mmol/ml versus 0.2±0.1 mmol/ml ), whereas copper-oxidized control LDL was 3.4±0.8 mmol/ml. On agarose gel electrophoresis the mobilities of diabetic LDL and VLDL as well as oxidized LDL were increased (1.3-fold, 1.5-fold and 1.8-fold respectively).
Cellular uptake of LDL isolated from NIDDM patients
To examine the receptor-mediated cellular uptake of lipoproteins from NIDDM patients, increasing concentrations of 125I-labelled LDL (5-100 mg protein per ml ) and VLDL ( 1-20 mg protein per ml ) were incubated with glomerular epithelial cells. LDL receptors were upregulated by incubating the cells in a medium containing 10% (v/v) LDS for 48 h. Glomerular epithelial cells bound, internalized, and degraded normal and diabetic LDL and VLDL in a concentration dependent and saturable fashion. However, uptake and degradation of both diabetic LDL and VLDL were significantly lower compared to control lipoproteins. Scatchard plot analysis revealed lower maximum capacities for binding, internalization and degradation in the case of To investigate whether glomerular epithelial cells Scatchard analyses are generated from saturation curves.
possess scavenger receptors, the ability to internalize copper-oxidized LDL was tested. Binding, internalization, and degradation of oxidized LDL occurred non-specifically with low maximal capacities and low aÃnity, thus demonstrating that glomerular epithelial cells obviously do not express scavenger receptors (Figure 2 , Table 4 ).
EÂect of LDL isolated from NIDDM patients on cellular sterol synthesis and cholesterol esterification Incorporation of (14C) acetate into sterols. To determine the influence of diabetic lipoproteins on intracellular cholesterol metabolism, glomerular epithelial cells were incubated with LDL from patients and healthy controls. After 48 h of incubation in medium containing 10% LDS, the cells were incubated for 16 h with LDL at a final concentration of 10 mg protein per ml medium ( Figure 4A ). Diabetic LDL was less eÂective than control LDL in inhibiting sterol synthesis from acetic acid, most probably due to both lower receptormediated uptake and lower cholesterol content of the diabetic LDL.
(3H)-oleate incorporation into cholesteryl esters.
Receptor mediated endocytosis of lipoproteins results in a stimulation of acylcholesterol acyltransferase activity. As expected, LDL stimulated the incorporation of labelled oleate into cholesteryl esters in glomerular epithelial cells. Diabetic LDL were less eÂective in stimulating cholesteryl esterification than control LDL ( Figure 4B) .
Discussion
Clinical studies demonstrate that dyslipidaemia, especially in combination with high blood pressure, accelerates the progression of diabetic nephropathy [2-5]. In fact, dyslipidaemia is already present in early stages of renal insuÃciency [3], when glomerular filtration rate falls below 70 ml/min. Diabetes mellitus has further substantial impact on lipoprotein concentration and composition. In most studies the issue of lipid-induced glomerular injury in diabetic nephropathy has focused primarily on the mesangial cell and matrix [32 ] . However, growing evidence indicates that the glomerular epithelial cell plays the predominant role in the development of progressive glomerulosclerosis [33] . In focal and segmental glomerulosclerosis as well as in diabetic nephropathy early lesions aÂect primarily the visceral glomerular epithelial cell and are found preferentially at the vascular pole of the glomerulus [34 ] .
Lesions at the vascular pole may expose podocytes to pathological conditions related to diabetic nephro- Table 4 . Concentration-dependent uptake of 125I-labelled lipoproteins from NIDDM patients (n=8 ) and healthy controls (n=12) as well as oxidized LDL (n=3) by human glomerular epithelial cells
125I-Lipoprotein
Binding Internalization Degradation catabolism, we performed additional experiments with was in an *P<0.05 vs control. All measurements were carried out in duplicate. acceptable range and diabetes was well controlled in our patients apoB,E receptor mediated clearance mechanisms were impaired. In this study we could determine pathy, lipoproteins can be directly in contact with the degree of glycation of apoB in serum. Because of glomerular epithelial cells. elevated serum glucose levels in NIDDM the amount This study demonstrates that glomerular epithelial cell metabolism of diabetic LDL was distinct from of glycated apoB was increased compared to controls.
Glucose is bound non-enzymatically to lysine groups initial step for the development of atherosclerotic and glomerulosclerotic lesions. of apoB-100. After in vitro glycation of LDL a reduced cellular uptake was observed in hepatocytes [35 ] and As demonstrated by this study glomerular epithelial cells are protected against lipid-loading by modified fibroblasts [36 ] . Schleicher et al. [37] reported that LDL uptake is only impaired in states of high artificial lipoproteins. Since the intracellular degradation of native lipoproteins is eÂective and LDL-receptors are in vitro glycation. However, several studies demonstrated a reduced catabolism of in vivo glycated LDL downregulated by the increase of intracellular cholesterol, glomerular epithelial cells would probably not in NIDDM patients and an accumulation of LDL in the circulation [38, 39] . The longer persistence of LDL become lipid-overloaded. Glomerulosclerotic lesions and foam cell formation might therefore preferentially in the circulation in hyperglycaemic environment may lead to a further increase in apolipoprotein glycation result from uptake of modified LDL by infiltrating macrophages and non-receptor mediated binding of [40] .
Recently Galeano et al. [41] reported, that diabetic modified lipoproteins to extracellular mesangial matrix. LDL were smaller than control LDL. These findings
